<DOC>
<DOCNO>
EP-0011142
</DOCNO>
<TEXT>
<DATE>
19800528
</DATE>
<IPC-CLASSIFICATIONS>
A61P-37/00 C07D-471/00 A61P-25/00 A61P-37/08 A61P-25/04 A61K-31/505 C07D-209/38 C07D-213/00 C07D-213/61 C07D-209/00 <main>C07D-471/04</main> C07D-471/04 A61P-29/00 A61K-31/517 A61P-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
pyrido (2,1-b) quinazolinones, their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
schering agde<sep>schering aktiengesellschaft berlin und bergkamen<sep>schering aktiengesellschaftd-13342 berlinde<sep>schering aktiengesellschaft berlin und bergkamen  <sep>
</APPLICANT>
<INVENTOR>
biere helmut dr<sep>bottcher irmgard dr<sep>kapp joachim-friedrich dr<sep>biere, helmut, dr.<sep>bottcher, irmgard, dr.<sep>kapp, joachim-friedrich, dr.<sep>biere, helmut, dr.zeltinger strasse 15d-1000 berlin 28de<sep>böttcher, irmgard, dr.rodelbahnpfad 5d-1000 berlin 28de<sep>kapp, joachim-friedrich, dr.ludolfinger weg 51d-1000 berlin 28de<sep>biere, helmut, dr.<sep>bottcher, irmgard, dr.<sep>kapp, joachim-friedrich, dr.<sep>biere, helmut, dr.zeltinger strasse 15d-1000 berlin 28de<sep>böttcher, irmgard, dr.rodelbahnpfad 5d-1000 berlin 28de<sep>kapp, joachim-friedrich, dr.ludolfinger weg 51d-1000 berlin 28de<sep>
</INVENTOR>
<ABSTRACT>
Pyrido [2,1-B] Chinazolinone derivatives of the general formula I wherein X is a cyano group, a hydroxyamidocarbonyl group, a carbamoyl group, a 5-tetrazolyl group, a carbo xyl group whose salts with physiologically acceptable bases whose esters and amides with physiologically self-oblique alcohols and amines, R₁ a hydrogen atom or a methyl group and R₂ to R₅ hydrogen atoms, halogen atoms, 1 to 4 carbon atoms containing alkyl groups, trifluoromethyl group pen, carboxyl groups, thiocyan groups, methylthiogrupps, methylsulfinyl groups, methylsulfonyl groups, methylsulfonimidoyl groups and or methylsulfonamido groups mean with the Specification that 2 or 3 of the GRUP PEN R₂ to R₅ represent hydrogen atoms, as well as their salts with physiologically harmless acids or bases, are pharmacologically active substances and are suitable for example for the treatment of invalidation processes, polyarthritis, neurodermitis, asthma bronchial, HE UFER, Dysmenorrhea, Migraine u. a. The compounds can be prepared, for example, under the conditions of the UllMan Flection, for example. b. 2- (8-bromo-11-oxo-11h-pyrido [2,1-B] quinazoline-2-yl) - propionic acid from 2- (4-amino-3-carboxy-phenyl) propionic acid and 2.5-dibrompyridine .
</ABSTRACT>
</TEXT>
</DOC>
